GLOBALMED TECHNOLOGIES USA, INC.
FL, FLORIDA

GlobalMed Technologies USA Inc. “GMT”; is a Biomedical company incorporated for the purpose of manufacturing, distributing and implementating a state of the art Photonic Corpuscular Irradiation System, consisting of the GMT PCI 1 Blood Irradiator, the GMT Disposable Kit and the GMT Cuvette (Irradiation Chamber). Although we can effectively treat any blood borne disease, the company will initially provide its treatment for current and future potential catastrophic diseases such as HIV/AIDS, EBOLA, Leishmaniasis, and Hepatitis C; to name a few. GMT is also including treatments for Laminitis (in Cattle and Horses), a Sterilization system for Blood Products (Blood Bank Industry) and a unique one of a kind Organ Transplant Sterilization Process, which in the future will enable us to transplant organs without the need for matching and with no possibility of rejection thereby eliminating the need for Anti-Rejection Medications. GMT is a Bio Medical Technology Company dedicated to the treatment of Catastrophic Diseases. GMT has patented it’s process, products and technology. Our mission is to provide a Bio Medical treatment that eradicates every Pathogen These are the people that we want to help, the ones with no hope, the downtrodden, the poor. Making our treatment affordable to all nations. In 2003 he received a U.S. patent for his product and process. In 2004 a government approved, Phase I Controlled Clinical Trial was conducted on 36 patients with acute and chronic HIV/AIDS. These patients’ viral loads were reduced by 85 to 99% and their CD4-cells (T-helper cells) were stabilized and reduced. Most importantly, 100% of opportunistic infections were eliminated and none of these patients were given anti-viral medications, either prior to or during the trial. Diseases being studied by GlobalMed Technologies USA